MAXILOSS Weight Advanced — Class I drug recall D-600-2013
Terminated recall by OLAAX International, reported 2013-06-19, distributed nationwide. Marketed Without an Approved NDA/ANDA: product contains sibutramine, a previously approved FDA drug removed fr
| Recall number | D-600-2013 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | OLAAX International, Bartow, FL, United States |
| Recall initiated | 2013-02-12 |
| Classified | 2013-06-13 |
| Reported by FDA | 2013-06-19 |
| Terminated | 2019-10-01 |
| Distributed | Nationwide (US) |
| Countries outside the US | BO, VE |
| Quantity | 600 boxes |
| Reason classes | unapproved product |
Product
MAXILOSS Weight Advanced, 225 mg proprietary blend of herbs, supplied in 36 count capsules in Green & Blue Boxes, Formulated and distributed by Olaax Corp, Lakeland, FL
Reason for recall
Marketed Without an Approved NDA/ANDA: product contains sibutramine, a previously approved FDA drug removed from the U.S. marketplace for safety reasons, making it an unapproved new drug.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-600-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.